While much of the company’s…
While much of the company’s recent focus has remained on [...]
While much of the company’s recent focus has remained on [...]
During a quarterly conference call, executives from Legend Biotech showed [...]
An Ultragenyx gene therapy has scored a win at the [...]
Small molecules make up almost half of the 20 most [...]
BridgeBio Pharma has taken another step toward the potential approval [...]
Evotec has escalated its already substantial reorganization, plotting an additional [...]
As AstraZeneca kicks off the third year of its hockey-themed [...]
Eli Lilly continued staggering sales growth in the fourth quarter, [...]
Veeva Systems, which offers life sciences companies cloud-based commercial management [...]
With a fresh leadership team settling in, CNS Pharmaceuticals is [...]